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Abstract 
Background: Transmission of the malaria parasite Plasmodium falciparum from humans to the mosquito vector 
requires differentiation of a sub-population of asexual forms replicating within red blood cells into non-dividing male 
and female gametocytes. The nature of the molecular mechanism underlying this key differentiation event required 
for malaria transmission is not fully understood.
Methods: Whole genome sequencing was used to examine the genomic diversity of the gametocyte non-produc-
ing 3D7-derived lines F12 and A4. These lines were used in the recent detection of the PF3D7_1222600 locus (encod-
ing PfAP2-G), which acts as a genetic master switch that triggers gametocyte development.
Results: The evolutionary changes from the 3D7 parental strain through its derivatives F12 (culture-passage derived 
cloned line) and A4 (transgenic cloned line) were identified. The genetic differences including the formation of chi-
meric var genes are presented.
Conclusion: A genomics resource is provided for the further study of gametocytogenesis or other phenotypes using 
these parasite lines.
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Background
The malaria parasite Plasmodium falciparum is a major 
threat to human health causing approximately 200 mil-
lion clinical cases per year and an estimated 438,000 
deaths [1]. Malaria control efforts focus mainly on the 
application of insecticides to kill the mosquito vector, 
and on the use of anti-malarial drugs that prevent the 
parasite from replicating/proliferating in the liver or 
red blood cell stages in the host. These tools reduce the 
prevalence of infection, but to reach elimination addi-
tional efforts will be required to interrupt transmission. 
For the malaria parasite to be transmitted from humans 
to the mosquito vector it requires differentiation of 
asexually replicating forms within red blood cells into 
non-dividing male and female gametocytes. Only one 
drug available in the clinic, primaquine, can kill mature 
gametocytes, but this is contra-indicated in patients 
with G6PD deficiency. Various pharmacological agents 
and even anti-malarial drugs, such as pyrimethamine 
and chloroquine have been shown to increase game-
tocyte production [2–4]. Also, high asexual parasite 
density and diffusible factors in cultures can promote 
gametocyte formation [5]. Gametocytaemia is a sensi-
tive indicator of emerging drug resistance [6]. Increas-
ing gametocyte prevalence has been shown to precede 
measurable changes in parasite clearance or a decrease 
in cure rates. Interventions that disrupt the switch to 
sexual development that occurs in the human host could 
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represent a more effective tool for malaria control and 
eventually elimination.
Although gametocytes were first observed microscopi-
cally in blood films taken from patients in the tropics 
over a 100 years ago, the molecular mechanisms involved 
in commitment to gametocyte formation are still poorly 
understood. Certain pathways have been implicated in 
gametocytogenesis, including those producing phorbol 
ester and involved in cAMP signalling [7], but these find-
ings have not been verified using genetic approaches. Evi-
dence has been reported that a heterotrimeric G protein 
based pathway may be involved [8], but the absence of 
homologues in the parasite genome make this unlikely. 
A number of studies have sought to identify loci that 
might constitute the trigger for the switch from asexual 
replication to sexual commitment. Genes in the sub-
telomeric region of the right arm of chromosome 9 have 
been implicated in the inability to produce gametocytes, 
particularly the gene PF3D7_0935400 (gametocyte devel-
opment protein 1; Pfgdv1) [9–11]. Complementation 
with PF3D7_0935400 restores gametocyte production in 
a 3D7 gametocyte-deficient line, which has the subtelo-
meric region on chromosome 9 deleted [11]. A further 
16 genes associated with gametocyte production were 
identified by random transposon mutagenesis [12]. It has 
been reported that the PF3D7_1222600 gene (a member 
of the ApiAP2 family encoding PfAP2-G) is an epigeneti-
cally regulated genetic master switch that triggers game-
tocyte development [13]. This finding was supported by 
several independent experimental approaches, including 
the identification of Pfap2-g mutations in two gameto-
cyte non-producer (GNP) clonal lines, F12 and A4, both 
derived from the reference 3D7 clone. Using similar 
approaches the P. berghei AP2-G orthologue was shown 
to play the same role in this rodent malaria parasite [14].
The F12 strain is a well-studied GNP line [10], unable 
to produce either morphologically recognizable gameto-
cytes or very early sexual stages [15]. A4 is a cloned trans-
genic line that was transfected with a plasmid designed 
to functionally delete the phosphodiesterase gene (PDEδ, 
PF3D7_1470500). A4 was generated with the intention of 
investigating whether the absence of PDEδ had any effect 
on exflagellation. However, the line lost the ability to pro-
duce gametocytes following drug selection, but this phe-
notype was unrelated to PDEδ function [16]. Both F12 
and A4 clones do not have coding-sequence mutations 
or deletions within the sub-telomeric region of chromo-
some 9, nor on any other the 16 genes recently implicated 
in gametocyte development [13]. The only mutations 
found to be associated with the phenotype were those 
that disrupt the Pfap2-g gene [13].
Substantial genetic variation arises in clones that have 
been maintained in long-term culture, such as the F12 and 
A4 GNP lines. Genomic changes have been observed for 
several laboratory clones, including those derived from 
3D7 [17, 18] and can be responsible for different pheno-
types such as the non-production of gametocytes. Many of 
the mutations arising in vitro might not have an immediate 
selective advantage to the parasite. However in vivo, such 
apparently silent genetic changes might become important 
when a new environment (e.g., anti-malarial drugs) is pre-
sented and a selective advantage is suddenly introduced.
Here, a comprehensive analysis of the genomes of these 
two long-term cultured GNP lines using whole genome 
sequencing data and advanced computational methods 
is presented. The mutations identified in the two GNP 
lines were compared with the 3D7 Ref. [19] and with 
the sequence data of the parental 3D7 clone (referred 
here as “3D7A”) used to generate the A4 line. The data 
were also compared with 930 P. falciparum field iso-
lates from several malaria endemic regions [20–22]. Any 
additional genetic changes were investigated, includ-
ing structural variants and rearrangements in the var 
genes that previously have been identified in clones 
subjected to long-term culture. The var genes are the 
most polymorphic gene family in P. falciparum, with 
60 loci distributed across the 14 chromosomes, both in 
the sub-telomeres and in internal regions. They encode 
the hypervariable P. falciparum erythrocyte membrane 
protein 1 (PfEMP1) that is critical for host immune eva-
sion. Finally, a genomic resource for the two GNP lines is 
established, thereby enabling the research community to 
further study these clonal lines that have lost the ability 
to undergo sexual differentiation.
Methods
Whole genome sequencing and statistical analysis
Genomic DNA was prepared for 3D7A, F12 and A4, 
and underwent whole genome sequencing using Illu-
mina technology with 76-base paired end fragment sizes 
[13, 23]. The raw sequence data (accession numbers 
ERS011445, ERS011446 and ERS011447) was processed 
as previously described [22]. In brief, the raw sequence 
data was aligned onto the 3D7 reference genome (ver-
sion 3.0) using the bwa-mem short read alignment algo-
rithm [25]. Single nucleotide polymorphisms (SNPs) 
and small insertions and deletions (indels) were identi-
fied using samtools and GATK, at a quality threshold of 
one error per one thousand basepairs (bp) [24, 25]. SNP 
genotypes were called using an established coverage-
based approach, and polymorphisms excluded if they 
had missing or mixed genotypes. Larger structural vari-
ants, including deletions and amplifications were iden-
tified using alignment, sequence coverage and de novo 
assembly and applying the Delly software [26]. Unless 
performing candidate region analysis, we only considered 
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genomic variants in regions that were unique (calculated 
by sliding 54  bp of contiguous sequence across the ref-
erence genome), non-sub-telomeric, and not in highly 
variable gene families (vars, stevors, rifins). De novo 
assembly was performed using velvet software [27], and 
was applied to localize the A4 plasmid insertion site. 
Genetic variation in the PF3D7_1222600 gene was char-
acterized using the tools described above for a set of 930 
field isolates sequenced by the MalariaGEN P. falcipa-
rum community project (accession numbers ERP000190 
and ERP000199) [20–22, 28]. This set included isolates 
from Bangladesh (n = 54), East Africa (n = 86; Kenya 17, 
Malawi 69), West Africa (n = 224; Burkina Faso 39, Gam-
bia 55, Guinea-Bissau 95, Mali 35) and Southeast Asia 
(n =  566, Thailand 91; Cambodia 253, Lao 35; Vietnam 
187). Pairwise population FST was used to assess allele 
frequency differences between regions, and computed 
using the function stamppFst in the R package.
Var gene characterization
A coverage-based framework was used to character-
ize the highly polymorphic var gene family [15]. This 
approach consisted of the quantification of the total 
coverage and the number of trans locus reads across the 
genome using a sliding window of 100 and 25  bp over-
lap. Trans locus reads are defined as pairs of mate reads 
that have been improperly paired, where one of the mate 
pairs is located inside a var gene and the other mate read 
is located outside the same gene. A peak on the cover-
age in the trans locus reads together with an alteration 
on the total coverage (increase or decrease) in a specific 
region can suggest the presence of a structural variant. 
The structural variants found in the var genes using this 
approach were compared with those found using the 
Delly software and were annotated accordingly.
Results and discussion
Polymorphisms identified in gametocyte non‑producer 
lines
The sequencing technology yielded in excess of thirty-six 
million 76 base-pair reads for each of the 3D7A, F12 and 
A4 cloned lines; their alignment led to an excess of 100-
fold median coverage and over 98 % of the genome with 
at least fivefold coverage (Table  1; Fig.  1). A set of 178 
high quality SNPs were identified, of which 109 (61.2 %) 
positions were found in unique and non-sub-telomeric 
regions. The majority (98/109) of SNPs had the same gen-
otype across the 3 clones but different from the reference 
allele (Table  1; Fig.  1). Others have also identified dif-
ferences between 3D7 clones and the reference genome 
[17, 18]. These discrepancies could be due to mutations 
introduced during long-term culture. It is also possible 
that some are potential sequencing or assembly errors in 
the 3D7 reference. Six of these SNPs cause a non-synon-
ymous change in the protein and one introduces a stop 
codon in comparison to the reference (Additional file 1: 
Table S1). In the mitochondria and apicoplast organelles 
we found 2 and 12 SNPs respectively, but again the three 
strains had the same alleles, different from the 3D7 refer-
ence genome. No SNPs were unique for the 3D7A clone. 
Only 11 SNPs were unique to either two GNP strains, 
with no overlap in genes (Fig. 1; Additional file 1: Table 
S1). It was assessed whether any of these SNPs were pre-
sent in a set of P. falciparum field isolates from coun-
tries in Africa and Asia [20–22]. Only one SNP, found 
in the Pfap2-g gene (PF3D7_1222600) that we previ-
ously described to affect gametocytes production in the 
F12 strain (as it introduces a stop codon) was identified 
in one sample from Guinea Bissau, but with a different 
mutation (S1308L). It is possible that this polymorphism 
has an effect on a gametocyte phenotype, but still allows 
transmission to mosquitoes. Unfortunately, no pheno-
typic data are available for the field isolates to study the 
effect of this SNP. 
The polymorphism list was extended by consider-
ing short indels. A set of high quality putative small 
indels (140 insertions/157 deletions, median length 2, 
range 1–20  bp) was identified (Additional file  2: Table 
S2; Fig.  1). The number of indels identified in unique 
and non-sub-telomeric genomic regions was 118 inser-
tions/119 deletions. Eighty-three indels were only pre-
sent in A4 or F12 (47 insertions, 36 deletions). Only 
Table 1 Genome sequencing and genetic variation
a Gametocyte non-producers
b From Illumina GA II 76 bp paired-end
c Mapped to 3D7 version 3.0 and excluding multi-copy apicoplast and mitochondria
d Total variation per sample, including shared genetic variation but only polymorphisms located in non-sub-telomeric and unique regions
Clone Number of read  
pairs (Millions)b
Median  
coveragec
% genome with at  
least 5× coverage
Genetic variationd
SNPs Indels Structural variants
3D7A 24.6 124 99.9 98 143 66
F12a 24.1 118 99.9 103 157 51
A4a 18 132 99.9 104 168 44
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two genes, PF3D7_0111200 (conserved Plasmodium 
protein, unknown function) and PF3D7_0726000 (a 
28 rRNA encoding gene) have indels in both lines. In 
the PF3D7_0111200 gene there was an insertion in the 
intron. The PF3D7_0726000 gene has one deletion and 
one insertion present in the two lines. The same inser-
tion was detected in 101 field isolates of the global set 
and the same deletion in 112. Only ten isolates have 
both. The indels detected in these genes most probably 
do not affect the production of gametocytes, as the inser-
tion in PF3D7_0111200 is intronic, and the indels in the 
PF3D7_0726000 gene are frequent in the field isolates 
(~10 %).
In this set of indels, the insertion in the pfap2-g gene 
in the A4 strain that results in a reading frame shift and 
introduction of stop codons (Additional file  2: Table 
S2; Chromosome 12: 913765) was identified. This is the 
only protein-coding gene having polymorphisms in both 
strains that affect the coding sequence, introducing stop 
codons. These polymorphisms are responsible for the 
non-gametocyte production phenotype, as previously 
described [13].
Genetic diversity of Pfap2‑g in Plasmodium falciparum field 
isolates collected across the globe
A polymorphism map using a set of P. falciparum 
genomes from Africa and Asia indicated that 91 SNPs 
(supported by at least two isolates) reside within the 
PF3D7_1222600 gene (Additional file  3: Table S3), and 
only 37 (41  %) are present at a minor allele frequency 
of more than 5 % (Fig. 2). Of these, 29 were non-synon-
ymous mutations. Some of the mutations appear to be 
more common in malaria endemic regions, including the 
SNPs in positions 907264 (K21R, FST 0.41, East Africa vs 
Southeast Asia), 910153 (K984T, FST 0.35, West Africa vs 
Southeast Asia), 910741 (G1180E, FST 0.41, West Africa 
vs Southeast Asia), 913124 (K1974N, FST 0.31, West 
Africa vs Southeast Asia), 913157 (N1985  K, FST 0.53, 
Fig. 1 Venn diagram summarizing the polymorphisms found in A4, F12 and 3D7A clone lines. SNPs, insertions and deletions (indels) and structural 
variants (SVs) identified in unique and non-sub-telomeric regions of the core genome
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East Africa vs Southeast Asia) and 914331 (Q2377K, 
FST > 0.67, Southeast Asia). Forty-six indels were identi-
fied but none change the protein frame shift nor intro-
duce stop codons (Additional file  3: Table S3). These 
results emphasize the importance of this gene for para-
site transmission, as no loss-of-function was detected in 
the field isolates.
Structural variation in the core genome and sub‑telomeric 
regions
Deletions, translocations and amplifications of large 
chromosomal stretches have been observed in P. falcipa-
rum lines following long-term in vitro culture as well as 
in field isolates [17, 18]. The sequence data were exam-
ined for structural variants in these parasite lines. Few 
structural variants were found within the core genome 
(Additional file  4: Table S4; Fig.  1), consisting mostly of 
deletions with an average length of 250  bp, and located 
predominantly in non-coding regions. No truncation on 
chromosome 9, which has been previously implicated 
in the inability to produce gametocytes in  vitro, was 
observed in these parasite lines, as previously described 
(Additional file 5: Figure S1) [9–11]. In the A4 strain we 
detected a possible deletion in a non-coding region in 
the telomeric region of chromosome 9 (Additional file 5: 
Figure S1). Rearrangements in chromosomal sub-telo-
meric regions were found, particularly between the var 
family gene members. Previous studies have observed 
recombination between sub-telomeric var genes involv-
ing those located either in the immediate vicinity on 
the same chromosome, or on different chromosomes 
[17, 18]. These rearrangements retain the frame-shift of 
the var genes and therefore form functional loci. Four 
putative rearrangements all involving neighbouring var 
genes were detected. Two chimeric genes generated by 
recombination between two adjacent var genes were 
Fig. 2 Allele frequencies of the SNPs in the PF3D7_1222600 gene across regions: West Africa (green), East Africa (red), Bangladesh (black), and South-
east Asia (blue). All mutations shown on upper axis (red tick marks = synonymous changes, black tick marks = non-synonymous; black text = with FST 
values > 0.3)
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identified: (i) PF3D7_0421100 and PF3D7_0421300 
(chromosome 4) found in F12, and (ii) PF3D7_1240400 
and PF3D7_1240600 (chromosome 12) detected in all 
three lines (Fig.  3a, b). Chimeric var genes involving 
exactly these pairs of adjacent genes have been reported 
previously in 3D7 clones [17]. More complex rearrange-
ments were detected, including duplication of var genes 
and formation of chimeras in the same region and chi-
meric genes formed by multiple cross-overs in between 
the same two adjacent genes (Fig. 3b–d). These were only 
detected in single isolates. The generation of chimeric var 
genes is a critical mechanism for immune invasion, and it 
has been proposed that these genes have a recombination 
rate of up to 0.2 % per life cycle (in vitro) [17]. This means 
that millions of new antigenic structures could possibly 
be produced in a single infected individual per day, giv-
ing the parasite one-upmanship in relation to the host 
immune system.
Typically, var genes contain two exons. Across the 
three strains, we detected a highly conserved area in the 
intronic region between the two exons. This intronic 
region seems to have very high coverage because the 
mate sequenced paired-reads map to almost all of the 
other var genes in all chromosomes. This region has been 
reported previously and experimental studies have shown 
that the conserved var introns are important regulatory 
elements [29, 30]. The regulation of var gene expression 
and silencing is closely linked to the regulation of sexual 
commitment, and both mechanisms are controlled by 
the same epigenetic machinery. The knockdown of the 
heterochromatin protein 1 (PF3D7_1220900) and a his-
tone deacetylase (PF3D7_1008000) promote gametocy-
togenesis and leads to de-regulation of mutually exclusive 
var gene expression [30–32]. It is not known whether 
disruptions in var gene expression, due to e.g., chroma-
tin modifications, also affect var gene recombination 
and, therefore, antigenic diversity. It has been suggested 
that introducing malaria control programs may increase 
parasite virulence in some circumstances [33]. The share 
of the core epigenetic machinery between these funda-
mental parasitic processes should be taken into account 
during control interventions (e.g., vaccine introduction) 
as blocking one process might unexpectedly affect the 
other process.
Location of the A4 plasmid insertion sites 
following transfection and drug selection
The A4 is a cloned transgenic line that was originally 
generated with the intention of investigating whether 
the absence of the phosphodiesterase gene (PDEδ, 
PF3D7_1470500) had any effect on exflagellation. The A4 
clone harbours a whole plasmid (7  kbp; more than one 
copy) designed to delete the PDEδ gene [34]. Following 
drug selection, this transgenic line lost the ability to pro-
duce gametocytes, but this phenotype was unrelated to 
PDEδ function. Importantly, it was subsequently shown 
using another cloned line in which the PDEδ gene had 
been successfully disrupted that whilst the production of 
gametocytes was unaffected, there was a severe reduc-
tion in the ability to undergo gametogenesis [16]. The A4 
sequence data was used to confirm the genomic insertion 
of the plasmid and the possibility that integration hap-
pened at more than one site and disrupted other genes. 
De novo assembly of the reads led to a contig of length 
~10  kbp, containing the ~7  kbp intact plasmid (derived 
from pHTK [35]), and a flanking 3  kbp region. A blast 
search of the contig to the reference genome indicated 
that the P. falciparum-derived elements of the plasmid 
matched to their respective chromosome sites with at 
least 99  % identity. In particular, the 3D7 derived con-
tig regions 1–845, 5510–6062, 6269–7134, 7360–10303 
matched to chromosome 14 (2883802-2884646, PDEδ), 7 
(381591-381037, HSP90), 14 (2882276-2883143, PDEδ), 
and 14 (1369973–1372928, PF3D7_1434300, HOP—
Hsp70/Hsp90 organizing protein), with 99.8, 98.7, 99.1 
and 99.5  % identity, respectively. Pulse field blot analy-
sis of A4 indicated an insertion of the plasmid within 
chromosome 14 [34], leaving the PDEδ (located in 
2882766–2886082) and HOP (PF3D7_1434300 located 
in 1372903–13745970) regions as potential candidates 
for insertion. Regions neighbouring the HOP and PDEδ 
(2882276–2883143) genes showed an excess of read 
(See figure on next page.) 
Fig. 3 Chimeric var genes. a For all clone lines, there is twofold increase coverage for the second part of PF3D7_1240400 (dark blue) and the first 
part of the adjacent gene, PF3D7_1240600 (light blue). The duplication-chimera was formed by the fusion of the half of PF3D7_1240600 and half of 
PF3D7_1240400, the var gene immediately adjacent. b For F12, a twofold increase coverage was observed for the second part of PF3D7_0421100 
(green), and the first part of the adjacent gene, PF3D7_0421300 (dark blue) indicating a duplication-chimera formed by duplicating half of 
PF3D7_0421100 and the other half of PF3D7_0421300. For the A4 and 3D7A strains an increased coverage of the second half of PF3D7_0420700, 
the full genes PF3D7_0420900 and PF3D7_0421100 and first half of gene PF3D7_0421300, was observed. This indicates a duplication of the genes 
PF3D7_0420900 and PF3D7_0421100 and a chimeric gene formed by duplicating half of PF3D7_0420700 and half of PF3D7_0421300. c For 3D7A, there 
is twofold increase coverage for the second part of PF3D7_0712300 (light blue), the whole of PF3D7_0712400 (lilac) and the first part of the adjacent 
gene PF3D7_0712600 (dark blue). It indicates a duplication of the full gene PF3D7_0712400 and a duplication-chimera formed by duplicating half 
of PF3D7_0712300 and half of PF3D7_0712600; d For A4, there is twofold increase in coverage of several regions of PF3D7_0412400 (light blue) and 
PF3D7_0412700 (dark-blue) only for A4. It indicates a chimeric gene formed by multiple cross-overs between the two adjacent genes
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coverage suggesting potential insertion sites for the plas-
mid (Additional file  6: Figure S2). To localize the exact 
plasmid integration site, the 3 kbp of the plasmid flanking 
sequence generated when performing de novo assembly 
of the plasmid was used. This flanking region contains 
pair-reads that mapped both the plasmid and the HOP 
region (1369961–1372928), confirming this location as a 
likely site of plasmid integration (Additional file 6: Figure 
S2). Excess coverage detected in two PDEδ regions cor-
responds to the two sequences that were inserted into the 
vector.
This sequence data analysis indicates that it is possible 
that integration occurred in a different genomic loca-
tion to that intended, and that care must be taken when 
interpreting the observed phenotype. The application 
of whole genome sequencing and new reverse genetic 
methodology will ensure such issues will be less problem-
atic in future.
Prediction of gametocyte/sexual development genes using 
DNA binding sequence motifs
A large proportion of P. falciparum genes lack a known 
function. Using a bioinformatic approach it is possible 
to identify genes that could function at specific P. falci-
parum developmental stages, and take into account simi-
larities in gene expression patterns to predict function 
(‘guilt by association’). By applying this method, a study 
using stage-specific gametocyte mRNA preparations 
in conjunction with microarray analysis and using ‘guilt 
by association’ approach, generated a ‘sexual develop-
ment’ cluster containing 246 genes [36]. A palindromic 
sequence (TGTANNTACA) was identified in the 5′ UTR 
of 65 genes in this cluster [36]. The A4 and F12 whole 
genome sequence data were scanned for this motif and 
23 genes were found, seven overlapping with the 65 in 
the cluster. There was also a scan for the consensus DNA-
binding preference of the transcription factor PfAP2-G 
that binds to specific motifs in the 5′ upstream region 
of early gametocyte genes to turn on transcription [37]. 
Fifty-one genes were identified, 11 also having the palin-
dromic sequence and five of them overlapping with the 
65 genes in the sexual development cluster (Additional 
file  7: Table S5). According to Illumina-based sequenc-
ing of P. falciparum 3D7 mRNA from gametocytes and 
erythrocytic stages [38], these 11 genes have higher 
expression during the sexual stages. Three of these genes 
were present in the guilt by association data set. This 
overlap could suggest that the two motifs, identified by 
independent means, may have a relationship in terms of 
determining timely expression of genes, particularly at 
the onset of gametocyte/sexual development, as the tran-
scription factor PfAP2-G seems to regulate the expres-
sion of early gametocyte genes.
The small overlap between the various datasets may 
indicate that other regulatory motifs besides the two 
analysed here, are important during the sexual stage. 
Overall, these types of approach, that integrate data from 
varying bioinformatics and gene expression studies, are 
important to identify target genes for further functional 
work, particularly when so many genes in the P. falcipa-
rum genome are hypothetical proteins. However, several 
genes may be missed, especially if they have low expres-
sions levels, are regulated by different mechanisms or 
involved in negative regulation. Moreover, there is the 
need to support gene transcription data particularly 
with quantitative proteomics, to generate more robust 
hypotheses.
Conclusion
A comprehensive analysis is presented of the three P. 
falciparum genomes that were previously used as part 
of a study to determine that the transcriptional regula-
tor AP2-G is a key determinant of sexual differentia-
tion. These cloned lines have been in long-term culture, 
so as expected several SNPs, indels, structural variants 
and some new chimeric var genes were identified. The 
acquisition of genetic variants and the recombination of 
the var genes during mitosis provide the parasite with a 
mechanism that can generate an enormous amount of 
genetic diversity, which could lead to selective advantage. 
These mutations might be phenotypically undetectable or 
may cause a visible phenotype, as in the case of the game-
tocyte non-production in the F12 and A4 clones. Also, 
by performing whole genome sequencing of a trans-
genic line we have identified an unexpected integration 
site. This finding may motivate others to take this step 
to identify any additional changes that have occurred in 
transgenic lines that might potentially contribute to a 
phenotype. These lines were fundamental to identifying 
the Pfap2-g gene, and they provide an important tool to 
understand gametocytogenesis in  vitro. There are still 
outstanding questions concerning how sexual commit-
ment occurs in vivo, and whether this locus may be useful 
in predicting and monitoring transmission. Ultimately, 
fully understanding the molecular events underpinning 
gametocyte production could lead to a therapeutic which 
totally prevents sexual development and thereby blocks 
transmission. The A4 and F12 gametocyte non-produc-
ing lines and their sequence data will be a useful resource 
for future studies looking to translate biological insights 
into malaria control measures.
Availability of supporting data
The sequence data were generated by the Malaria 
Programme at the Wellcome Trust Sanger Institute 
and are publically available from the EBI short read 
Page 9 of 10Campino et al. Malar J  (2016) 15:229 
archive (accession numbers: Clonal strains ERS011445, 
ERS011446 and ERS011447; field isolates ERP000190 and 
ERP000199). The data can also be accessed and browsed 
through the Pf3k web application (www.malariagen.net/
apps//pf3k).
Abbreviations
SNPs: single nucleotide polymorphisms; GNP: gametocyte non-producer; 
indels: insertions and deletions; bp: basepairs; SVs: structural variants.
Authors’ contributions
SC, DAB, and TGC conceived and designed the study; SC, ET, LGD, CJT, ZG 
and PA performed laboratory experiments, contributed biological samples, 
microarray, sequencing or phenotypic data; SC, EDB, SAA and TGC performed 
the statistical analysis; SC and DPK led the sequencing effort. SC, TGC and DAB 
wrote/drafted and finalized the manuscript with contributions from all other 
authors. All authors read and approved the final manuscript.
Author details
1 Faculty of Infectious and Tropical Diseases, London School of Hygiene & 
Tropical Medicine, London, UK. 2 The European Molecular Biology Organiza-
tion, Heidelberg, Germany. 3 Centre for Immunity, Infection and Evolution, 
University of Edinburgh, Edinburgh, UK. 4 Wellcome Trust Centre for Human 
Genetics, University of Oxford, Oxford, UK. 5 Wellcome Trust Sanger Institute, 
Hinxton, Cambridgeshire, UK. 6 Dipartimento di Malattie Infettive, Paras-
sitarie ed Immunomediate, Istituto Superiore di Sanità, Rome, Italy. 7 Faculty 
of Epidemiology and Population Health, London School of Hygiene & Tropical 
Medicine, London, UK. 
Acknowledgements
DAB acknowledges support from the Wellcome Trust (Project Grant Ref 
WT094752, Senior Investigator Award Ref 106240). TGC is supported by the 
Medical Research Council UK (Grant numbers MR/K000551/1, MR/M01360X/1, 
MR/N010469/1), and SC by a MRC UK grant (MR/M01360X/1). This publication 
uses data from the MalariaGEN Plasmodium falciparum Community Project 
Additional files
Additional file 1: Table S1. SNPs identified in the three lines 3D7A, A4 
and F12.
Additional file 2: Table S2. Insertions (INS) and deletions (DEL) identi-
fied in the three lines 3D7A, A4 and F12.
Additional file 3: Table S3. SNPs and Indels identified in the 
PF3D7_1222600 gene among P. falciparum field isolates from Africa and 
Asia.
Additional file 4: Table S4. Structural variants identified in the three 
lines 3D7A, A4 and F12.
Additional file 5: Figure S1. Coverage plots to evaluate evidence of 
truncation in the end of chromosome 9. (a) Coverage in the chromosome 
9 candidate region (20 genes from PF3D7_0935400 to PF3D7_0937300, 
shaded) showing no evidence of deletion (also confirmed using CGH 
data (not presented)) (A4, blue; 3D7A, green; F12, red); (b) Evidence of a 
deletion in a sub-telomeric non-coding region of chromosome 9 in the 
A4 strain, but not 3D7A or F12.
Additional file 6: Figure S2. Coverage plots showing potential inser-
tion points of the A4 plasmid. Regions neighbouring the (a) HOP and 
(b) PDE-delta genes showed an excess of read coverage suggesting 
potential insertion sites for the plasmid. The flanking region of the de novo 
assembled plasmid-contig maps to the HOP region confirmed this loca-
tion as a site of plasmid integration (Chromosome 14: 1369961–1372928). 
Excess coverage observed in two PDEδ regions corresponds to the two 
sequences that were inserted into the vector.
Additional file 7: Table S5. A scan for motifs in gene sequences (coding 
and UTR regions).
(www.malariagen.net/projects/parasite/pf ) as described in refs 18 and 19. 
Genome sequencing was performed by the Wellcome Trust Sanger Institute 
and the Community Project is coordinated by the MalariaGEN Resource Cen-
tre with funding from the Wellcome Trust (098051, 090770).
Competing interests
The authors declare that they have no competing interests.
Received: 2 January 2016   Accepted: 30 March 2016
References
 1. WHO. World Malaria Report 2015. Geneva: World Health Organization; 
2015.
 2. Baker DA. Malaria gametocytogenesis. Mol Biochem Parasitol. 
2010;172:57–65.
 3. A-Elbasit IE, Elbashir MI, Khalil IF, Alifrangis M, Giha HA. The efficacy of 
sulfadoxine-pyrimethamine alone and in combination with chloro-
quine for malaria treatment in rural Eastern Sudan: the interrelation 
between resistance, age and gametocytogenesis. Trop Med Int Health. 
2006;11:604–12.
 4. Puta C, Manyando C. Enhanced gametocyte production in Fansidar-
treated Plasmodium falciparum malaria patients: implications for malaria 
transmission control programmes. Trop Med Int Health. 1997;2:227–9.
 5. Williams JL. Stimulation of Plasmodium falciparum gametocytogenesis 
by conditioned medium from parasite cultures. Am J Trop Med Hyg. 
1999;60:7–13.
 6. Barnes KI, Little F, Mabuza A, Mngomezulu N, Govere J, Durrheim D, et al. 
Increased gametocytemia after treatment: an early parasitological indica-
tor of emerging sulfadoxine-pyrimethamine resistance in falciparum 
malaria. J Infect Dis. 2008;197:1605–13.
 7. Trager W, Gill GS. Plasmodium falciparum gametocyte formation in vitro: 
its stimulation by phorbol diesters and by 8-bromo cyclic adenosine 
monophosphate. J Protozool. 1989;36:451–4.
 8. Dyer M, Day K. Expression of Plasmodium falciparum trimeric G proteins 
and their involvement in switching to sexual development. Mol Biochem 
Parasitol. 2000;110:437–48.
 9. Day KP, Karamalis F, Thompson J, Barnes DA, Peterson C, Brown H, et al. 
Genes necessary for expression of a virulence determinant and for trans-
mission of Plasmodium falciparum are located on a 0.3-megabase region 
of chromosome 9. Proc Natl Acad Sci USA. 1993;90:8292–6.
 10. Alano P, Roca L, Smith D, Read D, Carter R, Day K. Plasmodium falciparum: 
parasites defective in early stages of gametocytogenesis. Exp Parasitol. 
1995;81:227–35.
 11. Eksi S, Morahan BJ, Haile Y, Furuya T, Jiang H, Ali O, et al. Plasmodium 
falciparum gametocyte development 1 (Pfgdv1) and gametocytogenesis 
early gene identification and commitment to sexual development. PLoS 
Pathog. 2012;8:e1002964.
 12. Ikadai H, Shaw Saliba K, Kanzok SM, McLean KJ, Tanaka TQ, Cao J, et al. 
Transposon mutagenesis identifies genes essential for Plasmodium falci-
parum gametocytogenesis. Proc Natl Acad Sci U S A. 2013;110:E1676–84.
 13. Kafsack BFC, Rovira-Graells N, Clark TG, Bancells C, Crowley VM, Campino 
SG, et al. A transcriptional switch underlies commitment to sexual devel-
opment in malaria parasites. Nature. 2014;507:248–52.
 14. Sinha A, Hughes KR, Modrzynska KK, Otto TD, Pfander C, Dickens NJ, et al. 
A cascade of DNA-binding proteins for sexual commitment and develop-
ment in Plasmodium. Nature. 2014;507:253–7.
 15. Silvestrini F, Bozdech Z, Lanfrancotti A, Di Giulio E, Bultrini E, Picci L, 
et al. Genome-wide identification of genes upregulated at the onset of 
gametocytogenesis in Plasmodium falciparum. Mol Biochem Parasitol. 
2005;143:100–10.
 16. Taylor CJ, McRobert L, Baker DA. Disruption of a Plasmodium falciparum 
cyclic nucleotide phosphodiesterase gene causes aberrant gametogen-
esis. Mol Microbiol. 2008;69:110–8.
 17. Claessens A, Hamilton WL, Kekre M, Otto TD, Faizullabhoy A, Rayner 
JC, et al. Generation of antigenic diversity in Plasmodium falciparum 
by structured rearrangement of Var genes during mitosis. PLoS Genet. 
2014;10:e1004812.
Page 10 of 10Campino et al. Malar J  (2016) 15:229 
•  We accept pre-submission inquiries 
•  Our selector tool helps you to find the most relevant journal
•  We provide round the clock customer support 
•  Convenient online submission
•  Thorough peer review
•  Inclusion in PubMed and all major indexing services 
•  Maximum visibility for your research
Submit your manuscript at
www.biomedcentral.com/submit
Submit your next manuscript to BioMed Central 
and we will help you at every step:
 18. Bopp SER, Manary MJ, Bright AT, Johnston GL, Dharia NV, Luna FL, et al. 
Mitotic evolution of Plasmodium falciparum shows a stable core genome 
but recombination in antigen families. PLoS Genet. 2013;9:e1003293.
 19. Gardner MJ, Hall N, Fung E, White O, Berriman M, Hyman RW, et al. 
Genome sequence of the human malaria parasite Plasmodium falcipa-
rum. Nature. 2002;419:498–511.
 20. Miotto O, Amato R, Ashley EA, MacInnis B, Almagro-Garcia J, Amaratunga 
C, et al. Genetic architecture of artemisinin-resistant Plasmodium falcipa-
rum. Nat Genet. 2015;47:226–34.
 21. Manske M, Miotto O, Campino S, Auburn S, Almagro-Garcia J, Maslen G, 
et al. Analysis of Plasmodium falciparum diversity in natural infections by 
deep sequencing. Nature. 2012;487:375–9.
 22. Ocholla H, Preston MD, Mipando M, Jensen ATR, Campino S, Mac-
Innis B, et al. Whole-genome scans provide evidence of adaptive 
evolution in Malawian Plasmodium falciparum isolates. J Infect Dis. 
2014;210:1991–2000.
 23. Auburn S, Campino S, Clark TG, Djimde AA, Zongo I, Pinches R, et al. An 
effective method to purify Plasmodium falciparum DNA directly from 
clinical blood samples for whole genome high-throughput sequencing. 
PLoS One. 2011;6:4–11.
 24. Preston MD, Assefa SA, Ocholla H, Sutherland CJ, Borrmann S, Nzila A, 
et al. PlasmoView: a web-based resource to visualise global Plasmodium 
falciparum genomic variation. J Infect Dis. 2014;209:1808–15.
 25. Li H. Toward better understanding of artifacts in variant calling from high-
coverage samples. Bioinformatics. 2014;30:2843–51.
 26. Rausch T, Zichner T, Schlattl A, Stütz AM, Benes V, Korbel JO. DELLY: struc-
tural variant discovery by integrated paired-end and split-read analysis. 
Bioinformatics. 2012;28:i333–9.
 27. Zerbino DR, Birney E. Velvet: algorithms for de novo short read assembly 
using de Bruijn graphs. Genome Res. 2008;18:821–9.
 28. Samad H, Coll F, Preston MD, Ocholla H, Fairhurst RM, Clark TG. 
Imputation-based population genetics analysis of Plasmodium falciparum 
malaria parasites. PLoS Genet. 2015;11:e1005131.
 29. Calderwood MS, Gannoun-Zaki L, Wellems TE, Deitsch KW. Plasmodium 
falciparum var genes are regulated by two regions with separate promot-
ers, one upstream of the coding region and a second within the intron. J 
Biol Chem. 2003;278:34125–32.
 30. Avraham I, Schreier J, Dzikowski R. Insulator-like pairing elements regu-
late silencing and mutually exclusive expression in the malaria parasite. 
Plasmodium falciparum. 2012;109:E3678–86.
 31. Brancucci NMB, Bertschi NL, Zhu L, Niederwieser I, Chin WH, Wampfler 
R, et al. Heterochromatin protein 1 secures survival and transmission of 
malaria parasites. Cell Host Microbe. 2014;16:165–76.
 32. Coleman BI, Skillman KM, Jiang RHY, Childs LM, Altenhofen LM, Ganter M, 
et al. A Plasmodium falciparum histone deacetylase regulates antigenic 
variation and gametocyte conversion. Cell Host Microbe. 2014;16:177–86.
 33. Mackinnon MJ, Gandon S, Read AF. Virulence evolution in response to 
vaccination: the case of malaria. Vaccine. 2008;26(Suppl 3):C42–52.
 34. Taylor CJ. The role of two cyclic nucleotide phosphodiesterases in the 
sexual development of Plasmodium falciparum and Plasmodium berghei. 
PhD Thesis. University of London; 2007.
 35. Duraisingh MT, Triglia T, Cowman AF. Negative selection of Plasmodium 
falciparum reveals targeted gene deletion by double crossover recombi-
nation. Int J Parasitol. 2002;32:81–9.
 36. Young JA, Fivelman QL, Blair PL, de la Vega P, Le Roch KG, Zhou Y, et al. 
The Plasmodium falciparum sexual development transcriptome: a micro-
array analysis using ontology-based pattern identification. Mol Biochem 
Parasitol. 2005;143:67–79.
 37. Campbell TL, De Silva EK, Olszewski KL, Elemento O, Llinás M. Identifica-
tion and genome-wide prediction of DNA binding specificities for the 
ApiAP2 family of regulators from the malaria parasite. PLoS Pathog. 
2010;6:e1001165.
 38. López-Barragán MJ, Lemieux J, Quiñones M, Williamson KC, Molina-Cruz 
A, Cui K, et al. Directional gene expression and antisense transcripts in 
sexual and asexual stages of Plasmodium falciparum. BMC Genomics. 
2011;12:587.
